Nebulized Heparin With N-Acetylcysteine and Albuterol Reduces Duration of Mechanical Ventilation in Patients With Inhalation Injury

J Pharm Pract. 2019 Apr;32(2):163-166. doi: 10.1177/0897190017747143. Epub 2017 Dec 12.

Abstract

Objective: Nebulized heparin has been proposed to improve pulmonary function in patients with inhalation injuries. The purpose of this study was to evaluate the impact of nebulized heparin with N-acetylcysteine (NAC) and albuterol on the duration of mechanical ventilation in burn patients.

Methods: This is a retrospective study evaluating mechanically ventilated adult patients admitted to a regional burn center with inhalation injury. Outcomes were compared between patients who were prescribed a combination of nebulized heparin with NAC and albuterol versus similar patients who did not.

Results: A total of 48 patients met inclusion criteria (heparin n = 22; nonheparin n = 26). Patients in the nonheparin group had higher percentage of total body surface area (TBSA) burned (29.00 [5.75-51.88] vs 5.25 [0.50-13.25] %TBSA; P = .009), longer duration of mechanical ventilation (6.50 [2.75-17.00] vs 3.00 [1.00-8.25] days; P = .022), and longer intensive care unit length of stay (LOS) (3.00 [3.00-28.75] vs 5.50 days [2.00-11.25]; P = .033). Upon regression, use of heparin was the only variable associated with reducing the duration of mechanical ventilation ( P = .039).

Conclusion: Nebulized heparin in combination with NAC and albuterol was associated with a significant reduction in the duration of mechanical ventilation.

Keywords: anticoagulation; critical care.

Publication types

  • Observational Study

MeSH terms

  • Acetylcysteine / administration & dosage*
  • Administration, Inhalation
  • Adult
  • Aged
  • Albuterol / administration & dosage*
  • Anticoagulants
  • Cohort Studies
  • Female
  • Heparin / administration & dosage*
  • Humans
  • Intensive Care Units
  • Male
  • Middle Aged
  • Nebulizers and Vaporizers
  • Respiration, Artificial / methods*
  • Retrospective Studies
  • Smoke Inhalation Injury / drug therapy
  • Smoke Inhalation Injury / therapy*

Substances

  • Anticoagulants
  • Heparin
  • Albuterol
  • Acetylcysteine